ASKGENE Pharma Granted Patent for Masked Cytokines
Summary
USPTO granted Patent No. US12600762B2 to ASKGENE PHARMA, INC. on April 14, 2026. The patent covers masked cytokines (prodrugs) and methods of use for stimulating the immune system, treating cancer, autoimmune diseases, or infectious diseases. The patent contains 19 claims and was filed on January 11, 2021 under Application No. 17787741.
What changed
USPTO granted Patent No. US12600762B2 to ASKGENE PHARMA, INC. for masked cytokine prodrug compositions and associated methods of use. The patent covers prodrug formulations for immune stimulation and therapeutic applications including cancer, autoimmune disease, and infectious disease treatment. The filing date was January 11, 2021, with 19 claims allowed.
Pharmaceutical companies developing cytokine-based therapeutics should monitor this patent for freedom-to-operate implications. The patent may cover competing masked cytokine approaches in the immunooncology and autoimmune treatment spaces. Inventors listed include Yuefeng Lu, Chunxiao Yu, Jian-Feng Lu, and Liqin Liu, with CPC classifications spanning multiple cytokine subcategories.
What to do next
- Monitor for updates
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Masked cytokines and methods of use thereof
Grant US12600762B2 Kind: B2 Apr 14, 2026
Assignee
ASKGENE PHARMA, INC.
Inventors
Yuefeng Lu, Chunxiao Yu, Jian-Feng Lu, Liqin Liu
Abstract
Provided herein are prodrugs and methods of making and using thereof for stimulating the immune system, or treating cancer, autoimmune or an infectious disease.
CPC Classifications
C07K 14/7155 C07K 14/54 C07K 14/5418 C07K 14/5433 C07K 14/55
Filing Date
2021-01-11
Application No.
17787741
Claims
19
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.